<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/7394</identifier>
				<datestamp>2021-08-27T21:41:06Z</datestamp>
				<setSpec>aabp:PT</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Isoniazid Therapy in Bovine Practice</dc:title>
	<dc:creator xml:lang="en">Schwarm, Mark A.</dc:creator>
	<dc:subject xml:lang="en">Isoniazid</dc:subject>
	<dc:subject xml:lang="en">cattle</dc:subject>
	<dc:description xml:lang="en">The basis of my talk is that here is a drug that is antibacterial with penetrating ability into fibrous tissue. To me, Isoniazid is indicated in chronic respiratory, soft tissue and bone infections in cattle and is definitely an economical addition to my treatment regimen.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>1983-11-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/7394</dc:identifier>
	<dc:identifier>10.21423/aabppro19837394</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 1983; 173-174</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/7394/7259</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1983 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
